HIGHLIGHTS
- who: . et al. from the Medical University Sofia, Bulgaria dei Tumori, Italy have published the Article: Tri uridine/tipiracil as a therapeutic option in real life setting of metastatic colorectal cancer: An ef cacy and safety analysis, in the Journal: (JOURNAL)
- what: This investigation is non-interventional, retrospective, single-center study that analyzed patients with metastatic colorectal cancer that received chemotherapy with trifluridine/tipiracil between May 2019 and May 2022 at the Oncology Institute Prof. Dr. Ion Chiricuu0163u0103 in Cluj-Napoca, Romania. The study was conducted in compliance with the principles of the Declaration of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.